Scientists identify targets to protect against anthracycline-induced cardiotoxicity

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified the mechanisms through which anthracyclines, a widely used class of anticancer drugs, damage the hearts of patients receiving this treatment. The study, published in the journal JACC: CardioOncology, also identifies possible treatments for this complication, which affects an estimated one-third of cancer survivors.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup